E
Eugene Braunwald
Researcher at Brigham and Women's Hospital
Publications - 1758
Citations - 278949
Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.
Papers
More filters
Journal Article
Survival to Adulthood in a Patient with Complete Transposition of the Great Vessels
TL;DR: The subject of this paper is a man who lived for 21 years with this malformation, which was a complete transposition of the great vessels in infancy.
Journal ArticleDOI
Mortality for women after acute myocardial infarction
Journal ArticleDOI
Antiplatelet therapy and platelet function testing.
Eugene Braunwald,Dominick J. Angiolillo,Eric R. Bates,Peter B. Berger,Deepak L. Bhatt,Christopher P. Cannon,Mark I. Furman,Paul A. Gurbel,Alan D. Michelson,Eric D. Peterson,Stephen D. Wiviott +10 more
TL;DR: The TIMI Study Group Cardiovascular Division Brigham and Women’s Hospital Department of Medicine Harvard Medical School, and the Center for Platelet Function Studies, Pediatrics, Medicine, and Pathology are used for this study.
Journal ArticleDOI
Efficacy and safety of edoxaban in patients with atrial fibrillation and active malignancy: an analysis of engage af – timi 48 randomized clinical trial
Christina Fanola,Christina Fanola,Christian T. Ruff,Christian T. Ruff,Sabina A. Murphy,Sabina A. Murphy,James Jin,James Jin,Anil Duggal,Anil Duggal,Michele Mercuri,Michele Mercuri,Elliott M. Antman,Elliott M. Antman,Eugene Braunwald,Eugene Braunwald,Robert P. Giugliano,Robert P. Giugliano +17 more
TL;DR: The aim is to evaluate the efficacy and safety of edoxaban in AF pts with active malignancy and the prothrombotic state and potential for bleeding associated with malignancies.
Journal ArticleDOI
The First Patient Clinically Diagnosed With Hypertrophic Cardiomyopathy
TL;DR: It has now been 50 years since the initial clinical description of hypertrophic cardiomyopathy and the first patient diagnosed with this disease has survived to date in good health with an active and productive lifestyle -- albeit with heart transplantation necessitated by an aggressive disease course with progression to the end-stage phase.